Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for LV Thrombus Prevention in Anterior MI
NCT06742567Phase 3Recruiting
- Sponsor
- National Institute of Cardiovascular Diseases
- Start
- Dec 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apixaban in left ventricular thrombus (LVT), sponsored by National Institute of Cardiovascular Diseases. Started Dec 2024; status: recruiting.
02
Drugs
apixaban
03
Conditions
left ventricular thrombus (LVT)
Beyond the preview
Go deeper on NCT06742567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06742567.